INDAZOLONES AS MODULATORS OF TNF SIGNALING

The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OSUMA, Augustine, BREINLINGER, Eric, IHLE, David, MULLEN, Kelly, FRIEDMAN, Michael, LO SCHIAVO, Gloria, Y, ARGIRIADI, Maria, MORYTKO, Michael, DIETRICH, Justin, D, WILSON, Noel, S
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	OSUMA, Augustine BREINLINGER, Eric IHLE, David MULLEN, Kelly FRIEDMAN, Michael LO SCHIAVO, Gloria, Y ARGIRIADI, Maria MORYTKO, Michael DIETRICH, Justin, D WILSON, Noel, S
description	The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3294726A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3294726A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3294726A13</originalsourceid><addsrcrecordid>eNrjZNDy9HNxjPL38fdzDVZwDFbw9XcJ9XEM8Q8KVvB3Uwjxc1MI9nT3c_Tx9HPnYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGRpYm5kZmjobGRCgBABOVJFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INDAZOLONES AS MODULATORS OF TNF SIGNALING</title><source>esp@cenet</source><creator>OSUMA, Augustine ; BREINLINGER, Eric ; IHLE, David ; MULLEN, Kelly ; FRIEDMAN, Michael ; LO SCHIAVO, Gloria, Y ; ARGIRIADI, Maria ; MORYTKO, Michael ; DIETRICH, Justin, D ; WILSON, Noel, S</creator><creatorcontrib>OSUMA, Augustine ; BREINLINGER, Eric ; IHLE, David ; MULLEN, Kelly ; FRIEDMAN, Michael ; LO SCHIAVO, Gloria, Y ; ARGIRIADI, Maria ; MORYTKO, Michael ; DIETRICH, Justin, D ; WILSON, Noel, S</creatorcontrib><description>The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180321&DB=EPODOC&CC=EP&NR=3294726A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180321&DB=EPODOC&CC=EP&NR=3294726A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OSUMA, Augustine</creatorcontrib><creatorcontrib>BREINLINGER, Eric</creatorcontrib><creatorcontrib>IHLE, David</creatorcontrib><creatorcontrib>MULLEN, Kelly</creatorcontrib><creatorcontrib>FRIEDMAN, Michael</creatorcontrib><creatorcontrib>LO SCHIAVO, Gloria, Y</creatorcontrib><creatorcontrib>ARGIRIADI, Maria</creatorcontrib><creatorcontrib>MORYTKO, Michael</creatorcontrib><creatorcontrib>DIETRICH, Justin, D</creatorcontrib><creatorcontrib>WILSON, Noel, S</creatorcontrib><title>INDAZOLONES AS MODULATORS OF TNF SIGNALING</title><description>The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDy9HNxjPL38fdzDVZwDFbw9XcJ9XEM8Q8KVvB3Uwjxc1MI9nT3c_Tx9HPnYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGRpYm5kZmjobGRCgBABOVJFg</recordid><startdate>20180321</startdate><enddate>20180321</enddate><creator>OSUMA, Augustine</creator><creator>BREINLINGER, Eric</creator><creator>IHLE, David</creator><creator>MULLEN, Kelly</creator><creator>FRIEDMAN, Michael</creator><creator>LO SCHIAVO, Gloria, Y</creator><creator>ARGIRIADI, Maria</creator><creator>MORYTKO, Michael</creator><creator>DIETRICH, Justin, D</creator><creator>WILSON, Noel, S</creator><scope>EVB</scope></search><sort><creationdate>20180321</creationdate><title>INDAZOLONES AS MODULATORS OF TNF SIGNALING</title><author>OSUMA, Augustine ; BREINLINGER, Eric ; IHLE, David ; MULLEN, Kelly ; FRIEDMAN, Michael ; LO SCHIAVO, Gloria, Y ; ARGIRIADI, Maria ; MORYTKO, Michael ; DIETRICH, Justin, D ; WILSON, Noel, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3294726A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>OSUMA, Augustine</creatorcontrib><creatorcontrib>BREINLINGER, Eric</creatorcontrib><creatorcontrib>IHLE, David</creatorcontrib><creatorcontrib>MULLEN, Kelly</creatorcontrib><creatorcontrib>FRIEDMAN, Michael</creatorcontrib><creatorcontrib>LO SCHIAVO, Gloria, Y</creatorcontrib><creatorcontrib>ARGIRIADI, Maria</creatorcontrib><creatorcontrib>MORYTKO, Michael</creatorcontrib><creatorcontrib>DIETRICH, Justin, D</creatorcontrib><creatorcontrib>WILSON, Noel, S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OSUMA, Augustine</au><au>BREINLINGER, Eric</au><au>IHLE, David</au><au>MULLEN, Kelly</au><au>FRIEDMAN, Michael</au><au>LO SCHIAVO, Gloria, Y</au><au>ARGIRIADI, Maria</au><au>MORYTKO, Michael</au><au>DIETRICH, Justin, D</au><au>WILSON, Noel, S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INDAZOLONES AS MODULATORS OF TNF SIGNALING</title><date>2018-03-21</date><risdate>2018</risdate><abstract>The disclosure provides indazolone compounds, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the disclosure may be useful for treating immunological and oncological conditions.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre ; ger
recordid	cdi_epo_espacenet_EP3294726A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	INDAZOLONES AS MODULATORS OF TNF SIGNALING
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T19%3A25%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OSUMA,%20Augustine&rft.date=2018-03-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3294726A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true